发布求助
文献互助 智能选刊 最新文献

Clinical ovarian cancer and other gynecologic malignancies最新文献

筛选
英文 中文
2022-RA-1438-ESGO Safety of total paracentesis in patients with malignant ascites from ovarian cancer: Results from the prospective, randomised ATLANTIS-trial 全穿刺治疗卵巢癌恶性腹水的安全性:来自前瞻性、随机atltis试验的结果
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.714
K. Pietzner, M. Passler, Maximilian Krafft, S. Alavi, R. Armbrust, Aarne Feldheiser, J. Sehouli
{"title":"2022-RA-1438-ESGO Safety of total paracentesis in patients with malignant ascites from ovarian cancer: Results from the prospective, randomised ATLANTIS-trial","authors":"K. Pietzner, M. Passler, Maximilian Krafft, S. Alavi, R. Armbrust, Aarne Feldheiser, J. Sehouli","doi":"10.1136/ijgc-2022-esgo.714","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.714","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76904591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-643-ESGO Mucinous ovarian cancers – a single institution analysis of clinicopathologic profile and survival outcomes 粘液性卵巢癌-临床病理特征和生存结果的单一机构分析
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.533
D. Bose, P. Rema
{"title":"2022-RA-643-ESGO Mucinous ovarian cancers – a single institution analysis of clinicopathologic profile and survival outcomes","authors":"D. Bose, P. Rema","doi":"10.1136/ijgc-2022-esgo.533","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.533","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85983228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-861-ESGO Transcriptome and genetic profile of epithelial ovarian carcinoma patients sensitive and resistant to platinum derivatives 对铂类衍生物敏感和耐药的上皮性卵巢癌患者的转录组和遗传谱
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.578
M. Hruda, V. Hlaváč, P. Holý, K. Šeborová, R. Vaclavikova, M. Mrhalová, Petr Černaj, J. Bouda, P. Souček, L. Rob
{"title":"2022-RA-861-ESGO Transcriptome and genetic profile of epithelial ovarian carcinoma patients sensitive and resistant to platinum derivatives","authors":"M. Hruda, V. Hlaváč, P. Holý, K. Šeborová, R. Vaclavikova, M. Mrhalová, Petr Černaj, J. Bouda, P. Souček, L. Rob","doi":"10.1136/ijgc-2022-esgo.578","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.578","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84737767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-245-ESGO Ovarian tumor frozen section, a multidisciplinary affair 卵巢肿瘤冷冻切片，一个多学科的事情
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.487
Mihaela Asp, Ebba Peber, P. Kannisto, A. Måsbäck, S. Malander
{"title":"2022-RA-245-ESGO Ovarian tumor frozen section, a multidisciplinary affair","authors":"Mihaela Asp, Ebba Peber, P. Kannisto, A. Måsbäck, S. Malander","doi":"10.1136/ijgc-2022-esgo.487","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.487","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84896866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1306-ESGO Effect of the COVID-19 pandemic on primary therapy and oncologic outcomes in women with advanced stage tubo-ovarian carcinoma in a tertiary cancer center 2019冠状病毒病大流行对三期肿瘤中心晚期输卵管卵巢癌患者主要治疗和肿瘤预后的影响
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-ESGO.683
A. Eriksson, Ragni K Idland, Larissa E. Hoffmann, T. Paulsen, Yun Wang, T. S. Jensen, Brynhildur Eyjólfsdóttir, O. Solheim, Pernille Bjerre Trent, B. Davidson, A. Dørum, M. Småstuen
{"title":"2022-RA-1306-ESGO Effect of the COVID-19 pandemic on primary therapy and oncologic outcomes in women with advanced stage tubo-ovarian carcinoma in a tertiary cancer center","authors":"A. Eriksson, Ragni K Idland, Larissa E. Hoffmann, T. Paulsen, Yun Wang, T. S. Jensen, Brynhildur Eyjólfsdóttir, O. Solheim, Pernille Bjerre Trent, B. Davidson, A. Dørum, M. Småstuen","doi":"10.1136/ijgc-2022-ESGO.683","DOIUrl":"https://doi.org/10.1136/ijgc-2022-ESGO.683","url":null,"abstract":"2022-RA-1306-ESGO Table 1Patient, tumor and treatment characteristicsResultsThere were 354 (76%) and 114 (24%) women in the pre-Covid and Covid cohorts, respectively. Demographics did not differ between cohorts (table 1). At multidisciplinary team evaluations there were no differences in allocation to primary surgery (PDS), interval surgery (IDS) or chemotherapy only (CT) between cohorts. Surgical complexity scores at PDS and IDS were similar in both cohorts. At PDS significantly more women in the covid cohort had residual disease <10 mm. Type and amount of chemotherapy did not differ between cohorts. Significantly more women in the Covid cohort received PARPi maintenance therapy. A significantly higher cumulative incidence of recurrence was found for the covid cohort (p<0.0003), figure 1a. For women undergoing exploratory laparotomy or IDS the risk of recurrence was higher in the Covid cohort than the pre-Covid cohort during initial 18 months after diagnosis, for IDS HR=2.75 [95% CI, 1.45–5.2], figure 1b.ConclusionDespite equal surgical capacity and favorable prognostic characteristics, women with advanced stage HGSC diagnosed during the Covid pandemic had a significantly higher risk of recurrence when compared to pre-covid cohort, particularly for women undergoing IDS.","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85280659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer 上皮性卵巢癌非选择多基因生殖系和体细胞基因检测的成本效益
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.685
Li Sun, M. Sobočan, Isabel V. Rodriguez, Xiaohui Wei, Ashwin Kalra, S. Oxley, M. Sideris, R. Morgan, D. Chandrasekaran, K. Rust, P. Spiliopoulou, Rowan E Miller, Shanthini M. Crusz, M. Lockley, N. Singh, A. Faruqi, Laura Casey, E. Brockbank, S. Phadnis, T. Mills-Baldock, F. El-Khouly, L. Jenkins, A. Wallace, Munaza Ahmed, Ajith Kumar, E. Swisher, C. Gourley, B. Norquist, D. Gareth Evans, R. Legood, R. Manchanda
{"title":"2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer","authors":"Li Sun, M. Sobočan, Isabel V. Rodriguez, Xiaohui Wei, Ashwin Kalra, S. Oxley, M. Sideris, R. Morgan, D. Chandrasekaran, K. Rust, P. Spiliopoulou, Rowan E Miller, Shanthini M. Crusz, M. Lockley, N. Singh, A. Faruqi, Laura Casey, E. Brockbank, S. Phadnis, T. Mills-Baldock, F. El-Khouly, L. Jenkins, A. Wallace, Munaza Ahmed, Ajith Kumar, E. Swisher, C. Gourley, B. Norquist, D. Gareth Evans, R. Legood, R. Manchanda","doi":"10.1136/ijgc-2022-esgo.685","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.685","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86845321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1517-ESGO Wroclaw comprehensive cancer centre 100 months experience in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in patients with peritoneal carcinomatosis – indications and complications of the procedure 在腹膜癌患者的细胞减少手术和腹腔热化疗(CRS+HIPEC)方面有100个月的经验-手术的适应症和并发症
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.734
K. Szewczyk, M. Jedryka, M. Bębenek
{"title":"2022-RA-1517-ESGO Wroclaw comprehensive cancer centre 100 months experience in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in patients with peritoneal carcinomatosis – indications and complications of the procedure","authors":"K. Szewczyk, M. Jedryka, M. Bębenek","doi":"10.1136/ijgc-2022-esgo.734","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.734","url":null,"abstract":"impact 5-year DFS (p=0.552). At univari-ate analysis the only significant variable affecting DFS was the performance of lymphadenectomy (HR:0.388; 95% CI:0.174 – 0.866;p=0.021). Abstract 2022-RA-1515-ESGO Figure 1 Conclusion In a retrospective multicenter series of low-grade endometrioid ovarian cancers apparently confined to the ovary, lymphadenectomy appeared to be associated with improved DFS. Adjuvant chemotherapy did not impact DFS. Nevertheless, the present results derive from a retrospective uncontrolled study, in which the indication for or against lym-phadenectomy/adjuvant chemotherapy was not prospectively defined, causing potential significant selection bias.","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84787463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-680-ESGO Safety and efficacy of MORAb-202 in patients with platinum-resistant ovarian cancer: results from the expansion part of a phase 1 trial in Japan MORAb-202在铂耐药卵巢癌患者中的安全性和有效性:来自日本1期试验扩展部分的结果
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.543
S. Nishio, M. Yunokawa, Koji Matsumoto, K. Takehara, K. Hasegawa, Y. Hirashima, H. Kato, H. Ikezawa, Maiko Nomoto, S. Hayato, Yohei Otake, Takuma Miura, K. Yonemori
{"title":"2022-RA-680-ESGO Safety and efficacy of MORAb-202 in patients with platinum-resistant ovarian cancer: results from the expansion part of a phase 1 trial in Japan","authors":"S. Nishio, M. Yunokawa, Koji Matsumoto, K. Takehara, K. Hasegawa, Y. Hirashima, H. Kato, H. Ikezawa, Maiko Nomoto, S. Hayato, Yohei Otake, Takuma Miura, K. Yonemori","doi":"10.1136/ijgc-2022-esgo.543","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.543","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81761460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1725-ESGO Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer- results of a multicentre NOGGO phase I and II study (TOPAZ) Pazopanib联合Topotecan治疗铂耐药或中敏感复发性卵巢癌患者——多中心NOGGO I期和II期研究结果(TOPAZ)
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.779
Tjadina Arndt, R. Chekerov, K. Pietzner, I. Yalcinkaya, U. Canzler, P. Wimberger, H. Strauß, S. Mahner, L. Woelber, N. de Gregorio, U. Hacker, E. V. Abel, R. Richter, J. Sehouli
{"title":"2022-RA-1725-ESGO Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer- results of a multicentre NOGGO phase I and II study (TOPAZ)","authors":"Tjadina Arndt, R. Chekerov, K. Pietzner, I. Yalcinkaya, U. Canzler, P. Wimberger, H. Strauß, S. Mahner, L. Woelber, N. de Gregorio, U. Hacker, E. V. Abel, R. Richter, J. Sehouli","doi":"10.1136/ijgc-2022-esgo.779","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.779","url":null,"abstract":"2022-RA-1715-ESGO Table 1 Univariate analysis of the risk of recurrence after the first surgery Factor Category Odds Ratio (IC 95%) P value Histology Serous 4 (0.6744003 23.72478) 0.10","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81396774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-RA-1111-ESGO Case studies as a valuable tool to improve physician competence regarding identification of patients and selection of treatment for newly diagnosed advanced ovarian cancer 病例研究作为一种有价值的工具来提高医生在新诊断的晚期卵巢癌患者识别和治疗选择方面的能力
Clinical ovarian cancer and other gynecologic malignancies Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.640
Ben Johnson, M. Cannon, J. Vandenbroucque, Yelena Parada, K. Lucero
{"title":"2022-RA-1111-ESGO Case studies as a valuable tool to improve physician competence regarding identification of patients and selection of treatment for newly diagnosed advanced ovarian cancer","authors":"Ben Johnson, M. Cannon, J. Vandenbroucque, Yelena Parada, K. Lucero","doi":"10.1136/ijgc-2022-esgo.640","DOIUrl":"https://doi.org/10.1136/ijgc-2022-esgo.640","url":null,"abstract":"","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83624335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书